Regular Article

British Journal of Cancer (2001) 84, 535–538. doi:10.1054/bjoc.2000.1628 www.bjcancer.com
Published online 13 February 2001

Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts)

S M Langezaal1, J F Graadt van Roggen1, A M Cleton-Jansen1, J J Baelde1 and P C W Hogendoorn1

1Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands

Received 16 August 2000; Revised 6 November 2000; Accepted 8 November 2000.

Top

Abstract

Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and conventional malignant melanoma may demonstrate significant morphologic overlap at the light microscopic and ultrastructural level. Consequently, the clinically relevant distinction between primary clear cell sarcoma and metastatic melanoma in the absence of a known primary cutaneous, mucosal or ocular tumour may occasionally cause diagnostic problems. A balanced translocation, t(12;22)(q13;q13), which can be detected, amongst others, using the reverse transcriptase polymerase chain reaction (RT-PCR) or fluorescent in situ hybridization (FISH), has been identified in a high percentage (50–75%) of clear cell sarcomas and is presumed to be tumour specific. Whether this chromosomal rearrangement is present in malignant melanoma has, to date, not as yet been studied by molecular genetic or molecular cytogenetic techniques. Using RT-PCR and FISH, a series of metastases from 25 known cutaneous melanomas and 8 melanoma cell lines (5 uveal and 3 cutaneous) were screened for the t(12;22)(q13;q13) translocation. Primers for RT-PCR were chosen based upon published breakpoint sequences. The Cosmids G9 and CCS2.2, corresponding to the 5' region of EWS and 3' region of ATF-1 respectively, were used as probes. The translocation was not identified in any of the melanomas or melanoma cell lines analysed in this study; in contrast this translocation was identified in 3 out of 5 clear cell sarcomas using these techniques. This allows distinction between translocation positive cases of clear cell sarcoma and malignant melanoma at a molecular genetic level. Consequently, in diagnostically challenging cases, this represents a valuable tool for the clinicopathologic differentiation between these two entities, with an important impact on patient management and prognosis. © 2001 Cancer Research Campaign

Keywords:

soft tissue tumour, sarcoma, clear cell sarcoma, malignant melanoma of soft parts, melanoma, chromosomal rearrangement; RT-PCR

Top

References

  1. Bridge JA, Borek DA, Neff JR and Huntrakoon M (1990) Chromosomal abnormalities in clear cell sarcoma. Implications for histogenesis. Am J Clin Pathol 93: 26–31 | PubMed | ISI | ChemPort |
  2. Bridge JA, Sreekantaiah C, Neff JR and Sandberg AA (1991) Cytogenetic findings in clear cell sarcoma of tendons and aponeuroses. Malignant melanoma of soft parts. Cancer Genet Cytogenet 52: 101–106 | Article | PubMed | ISI | ChemPort |
  3. Castellano M and Parmiani G (1999) Genes involved in melanoma: an overview of INK4a and other loci. Melanoma Res 9: 421–432 | Article | PubMed | ISI | ChemPort |
  4. Chung EB and Enzinger FM (1983) Malignant melanoma of soft parts. A reassessment of clear cell sarcoma. Am J Surg Pathol 7: 405–413 | PubMed | ISI | ChemPort |
  5. De Beuckeleer LH, De Schepper AM, Vandevenne JE, Bloem JL, Davies AM, Oudkerk M, Hauben E, Van Marck E, Somville J and Vanel D (2000) MR imaging of clear cell sarcoma (malignant melanoma of the soft parts): a multicenter correlative MR-pathology study of 21 cases and literature review. Skelet Radiol 29: 187–195
  6. de Waard-Siebinga I, Blom DR, Griffioen M, Schrier PI, Hoogendoorn E, Beverstock GC, Danen EHJ and Jager MJ (1995) Establishment and characterization of an uveal-melanoma cell line. Int J Cancer 62: 155–161 | Article | PubMed | ChemPort |
  7. Enzinger FM (1965) Clear-cell sarcoma of tendons and aponeuroses. An analysis of 21 cases. Cancer 18: 1163–1174 | PubMed | ISI | ChemPort |
  8. Epstein IL, Martin AO and Kempson R (1984) Use of a newly established cell line (SU-CCS-1) to demonstrate the relationship of clear cell sarcoma to malignant melanoma. Cancer Res 44: 1265–1274 | PubMed | ISI |
  9. Fletcher JA (1992) Translocation (12;22)(q13–14;q12) is a nonrandom aberration in soft-tissue clear-cell sarcoma. Genes Chrom Cancer 5: 184 | PubMed | ISI | ChemPort |
  10. Fletcher JA, Kozakewich HP, Hoffer FA, Lage JM, Weidner N, Tepper R, Pinkus GS, Morton CC and Corson JM (1991) Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med 324: 436–442 | PubMed | ISI | ChemPort |
  11. Graadt van Roggen JF, Mooi WJ and Hogendoorn PCW (1998) Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma: exploring the histogenetic relationship between these two clinicopathological entities. J Pathol 186: 3–7 | Article | PubMed | ChemPort |
  12. Graadt van Roggen JF, Bovee JVMG, Morreau J and Hogendoorn PCW (1999) Diagnostic and prognostic implications of the unfolding molecular biology of bone and soft tissue tumours. J Clin Pathol 52: 481–489
  13. Kindblom L-G, Lodding P and Angervall L (1983) Clear-cell sarcoma of tendons and aponeuroses. An immunohistochemical and electron microscopic analysis indicating neural crest origin. Virchows Arch 401: 109–128 | ISI | ChemPort |
  14. Ladanyi M (1995) The emerging molecular genetics of sarcoma translocations. Diagn Mol Pathol 4: 162–173 | Article | PubMed | ISI | ChemPort |
  15. Limon J, Debiec-Rychter M, Nedoszytko B, Liberski P, Babinska M and Szadowska A (1994) Aberrations of chromosome 22 and polysomy of chromosome 8 as non-random changes in clear cell sarcoma. Cancer Genet Cytogenet 72: 141–145
  16. Mooi WJ, Deenik W, Peterse JL and Hogendoorn PCW (1995) Keratin immunoreactivity in melanoma of soft parts (clear cell sarcoma). Histopathology 27: 61–65 | PubMed | ISI | ChemPort |
  17. Mrozek K, Karakousis CP, Perez-Mesa C and Bloomfield CD (1993) Translocation t(12;22)(q13;q12.2-12.3) in clear cell sarcoma of tendons and aponeuroses. Genes Chrom Cancer 6: 249–252
  18. Nedoszytko B, Mrozek K, Roszkiewicz A, Kopacz A, Swierblewski M and Limon J (1996) Clear cell sarcoma of tendons and aponeuroses with t(12;22)(q13;q12) diagnosed initially as malignant melanoma. Cancer Genet Cytogenet 91: 37–39
  19. Pedersen MI, Bennett JW and Wang N (1985) Nonrandom chromosomes, structural aberrations, and oncogenic loci in human malignant melanoma. Cancer Genet Cytogenet 20: 11–27
  20. Peulvé P, Michot C, Vannier JP, Tron P and Hemet J (1991) Clear cell sarcoma with t(12;22)(q13-14;q12). Genes Chromosomes Cancer 3: 400–402
  21. Piepkorn M (2000) Melanoma genetics: an update with focus on the CDKN2A(p16)/ARF tumor suppressors. J Am Acad Dermatol 42: 705–722 | Article | PubMed | ISI | ChemPort |
  22. Reeves BR, Fletcher CDM and Gusterson BA (1992) Translocation t(12;22)(q13;q13) is a nonrandom rearrangement in clear cell sarcoma. Cancer Genet Cytogenet 64: 101–103 | Article | PubMed | ISI | ChemPort |
  23. Rodriguez E, Sreekantaiah C, Reuter VE, Motzer RJ and Chaganti RSK (1992) t(12;22)(q13;q13) and trisomy 8 are nonrandom aberrations in clear-cell sarcoma. Cancer Genet Cytogenet 64: 107–110
  24. Speleman F, Colpaert C, Goovaerts G, Leroy JG and Van Marck E (1992) Malignant melanoma of soft parts. Further cytogenetic characterization. Cancer Genet Cytogenet 58: 176–179 | Article |
  25. Speleman F, Delattre O, Peter M, Hauben E, Van Roy N and Van Marck E (1997) Malignant melanoma of the soft parts (clear cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by t(12;22) translocation. Mod Pathol 10: 496–499 | PubMed | ISI | ChemPort |
  26. Stenman G, Kindblom L-G and Angervall L (1992) Reciprocal translocation t(12;22)(q13;q13) in clear-cell sarcoma of tendons and aponeuroses. Genes Chrom Cancer 4: 122–127 | PubMed | ISI | ChemPort |
  27. Travis JA and Bridge JA (1992) Significance of both numerical and structural chromosomal abnormalities in clear cell sarcoma. Cancer Genet Cytogenet 64: 104–106 | Article | PubMed | ISI | ChemPort |
  28. Vaandrager JW, Schuuring E, Zwikstra E, De Boer CJ, Kleiverda KK, Van Krieken JHJM, Kluin-Nelemans HC, Van Ommen GJB, Raap AK and Kluin PM (1996) Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. Blood 88: 1177–1182 | PubMed | ISI | ChemPort |
  29. Zucman J, Delattre O, Desmaze C, Epstein AL, Stenman G, Speleman F, Fletcher CDM, Aurias A and Thomas G (1993) EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nature Genet 4: 341–345 | Article |